Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed May 12, 2017 · 10-Q · 42 days after period end · 0001493152-17-005163
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Net Income | -$2.92M | -$12.26M | -$1.64M | -$323.65K |
| EPS Diluted | -$0.08 | -$0.35 | -$0.07 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 12, 2017 · 42 d after period end
